Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy.
Cost-Utility Analysis of Natalizumab as First-Line Treatment of Highly-Active Relapsing-Remitting Multiple Sclerosis in the Brazilian Public Healthcare System.
Identifying clues to molecular etiology of multiple sclerosis in South Indian patients.
[Sarcoid neuropathy].
Infectious and noninfectious granulomatosis in patient with multiple sclerosis: diagnostic dilemmas and followup.
Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.
Comparison of energy consumption in different clinical forms multiple sclerosis with normal subjects (cohort study).
Quaking Regulates Neurofascin 155 Expression for Myelin and Axoglial Junction Maintenance.
Cell death of spinal cord ED1(+) cells in a rat model of multiple sclerosis.
Alphab-crystallin is a target for adaptive immune responses and a trigger of innate responses in preactive multiple sclerosis lesions.
White Matter Injury in Ischemic Stroke.
Increased incidence of multiple sclerosis in systemic sclerosis: A nationwide cohort study.
Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.
Neuromyelitis optica phenotype associated with therapy-responsive acute peripheral neuropathy.
Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
A Meta-analysis of the relation between chemokine receptor 5 delta32 polymorphism and multiple sclerosis susceptibility.
New Perspectives in Pediatric Neurology-Multiple Sclerosis.
Normal Diffusion-Weighted MRI During the Acute Stage of Central Pontine Myelinolysis.
CD4(+)HLA-G(+) regulatory T cells: Molecular signature and pathophysiological relevance.
Sharing data from MS clinical trials: Opportunities, challenges, and future directions.
Decreased serum IL-27 and IL-35 levels are associated with disease severity in neuromyelitis optica spectrum disorders.
The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence.
Myelinating and demyelinating phenotype of Trembler-J mouse (a model of Charcot-Marie-Tooth human disease) analyzed by atomic force microscopy and confocal microscopy.
Characteristics of clinical and electrophysiological pattern of Charcot-Marie-Tooth 4C.
Anti-annexin antibodies, cholesterol levels and disability in multiple sclerosis.
Pages
« first
‹ previous
…
671
672
673
674
675
676
677
678
679
…
next ›
last »